Tagged with M&A,

Dealmaking in Asia: The Changing Role of Business Development
Karim Smaira – Founder & CEO; Kamel Ghammachi, Founder & Chairman, Genpharm
Cynthia Xin Wang – Head of Business Development Asia, Servier
J&J Pursues Medtech Growth with USD 13.1 Billion Shockwave Buyout
Camilia Benani – Partner, DLA Piper Morocco
Medtronic Continues Diabetes Pivot with USD 738m Acquisition of Korean Insulin Patch Maker EOFlow
Potential Impacts of the US Antitrust Environment on Biopharmaceutical M&A
Daniel Vella Friggieri – Regional CEO, Europe & Middle East, Aspen Pharmacare
BIO2023: Biogen CEO Slams IRA and Talks M&A Opportunities
Roche Banking on M&A Spree to Propel It Back Up Global Pharma Rankings
Transact to Transform: How can Biopharmas use Alliances & Partnerships to Drive Innovation?
Ipsen EVP and CBO Philippe Lopes-Fernandes on the company’s deal-making philosophy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here